About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- gemcitabine
- Procedure number
- PSUSA/00001519/202301
- Regulatory outcome
- Variation
Documents
Gemcitabine : List of nationally authorised medicinal products - PSUSA/00001519/202301
English (EN) (394.67 KB - PDF)
Gemcitabine : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001519/202301
English (EN) (161.36 KB - PDF)
български (BG) (246.15 KB - PDF)
español (ES) (97.17 KB - PDF)
čeština (CS) (177.54 KB - PDF)
dansk (DA) (99.05 KB - PDF)
Deutsch (DE) (93.58 KB - PDF)
eesti keel (ET) (156.4 KB - PDF)
ελληνικά (EL) (189.69 KB - PDF)
français (FR) (146.77 KB - PDF)
hrvatski (HR) (234.65 KB - PDF)
íslenska (IS) (176.66 KB - PDF)
italiano (IT) (197.31 KB - PDF)
latviešu valoda (LV) (242.27 KB - PDF)
lietuvių kalba (LT) (222.41 KB - PDF)
magyar (HU) (211.1 KB - PDF)
Malti (MT) (226.44 KB - PDF)
Nederlands (NL) (161.22 KB - PDF)
norsk (NO) (133.61 KB - PDF)
polski (PL) (173.96 KB - PDF)
português (PT) (184.94 KB - PDF)
română (RO) (154.88 KB - PDF)
slovenčina (SK) (129.57 KB - PDF)
slovenščina (SL) (169.41 KB - PDF)
Suomi (FI) (144.39 KB - PDF)
svenska (SV) (98.23 KB - PDF)